Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 8,062,000 | 7,644,000 | 3,171,000 | 3,123,000 | 2,158,000 |
| Depreciation Amortization | 7,013,000 | 5,222,000 | 3,467,000 | 1,736,000 | 6,290,000 |
| Income taxes - deferred | -2,102,000 | -1,706,000 | -1,224,000 | -441,000 | -3,442,000 |
| Accounts receivable | -109,000 | N/A | N/A | N/A | 347,000 |
| Other Working Capital | -3,066,000 | -5,992,000 | -6,871,000 | -3,336,000 | -2,172,000 |
| Other Operating Activity | 2,946,000 | 855,000 | 766,000 | 8,000 | 5,519,000 |
| Operating Cash Flow | $12,744,000 | $6,023,000 | $-691,000 | $1,090,000 | $8,700,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -2,869,000 | 1,322,000 | 3,996,000 | -1,326,000 | 13,464,000 |
| PPE Investments | -2,909,000 | -1,992,000 | -1,341,000 | -704,000 | -3,907,000 |
| Net Acquisitions | N/A | N/A | N/A | N/A | -43,430,000 |
| Purchase Of Investment | -180,000 | -75,000 | -108,000 | -35,000 | -204,000 |
| Sale Of Investment | 8,610,000 | 5,032,000 | 3,803,000 | 3,796,000 | 1,979,000 |
| Other Investing Activity | 0 | -12,000 | -18,000 | 1,000 | -180,000 |
| Investing Cash Flow | $2,652,000 | $4,275,000 | $6,332,000 | $1,732,000 | $-32,278,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 6,317,000 | 5,585,000 | 4,913,000 | -595,000 | 7,686,000 |
| Debt Issued | N/A | 0 | 0 | N/A | 30,831,000 |
| Debt Repayment | -2,250,000 | -2,250,000 | -2,250,000 | -1,250,000 | -2,569,000 |
| Dividend Paid | -9,512,000 | -7,132,000 | -4,752,000 | -2,372,000 | -9,247,000 |
| Other Financing Activity | -11,695,000 | -8,229,000 | -5,301,000 | -714,000 | -635,000 |
| Financing Cash Flow | $-17,140,000 | $-12,026,000 | $-7,390,000 | $-4,931,000 | $26,066,000 |
| Exchange Rate Effect | -66,000 | -37,000 | -46,000 | -28,000 | -40,000 |
| Beginning Cash Position | 2,917,000 | 2,917,000 | 2,917,000 | 2,917,000 | 468,000 |
| End Cash Position | 1,107,000 | 1,152,000 | 1,123,000 | 780,000 | 2,917,000 |
| Net Cash Flow | $-1,810,000 | $-1,765,000 | $-1,794,000 | $-2,137,000 | $2,448,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 12,744,000 | 6,023,000 | -691,000 | 1,090,000 | 8,700,000 |
| Capital Expenditure | -2,909,000 | -1,992,000 | -1,341,000 | -704,000 | -3,907,000 |
| Free Cash Flow | 9,835,000 | 4,031,000 | -2,032,000 | 386,000 | 4,793,000 |